Petroteq” or the “
Company”) (TSXV:PQE; OTC:PQEFF; FSE:PQCF), an integrated oil company focused on the development and implementation of its proprietary oil-extraction and remediation technologies, announces an amendment to the agreement it announced on December 28, 2020 with an arm’s length lender in respect of a debenture issued by Company to the lender on July 19, 2019 that matured on October 19, 2020 and a debenture issued by Company to the lender on September 17, 2019 that matured on December 17, 2020.
Under the amended agreement (i) the lender will only be converting the interest under the debentures into shares (581,026) at a deemed price of US$0.039 per share, (ii) the lender will not be converting the principal (US$490,000) under the debentures into shares at US$0.039 per share and instead has agreed to extend the maturity date of each debenture by 12 months with the conversion price of such debentures being increased from US$0.037 to US$0.0475, and
Alcon Inc. Investors: Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S.
Vivity X-WAVE technology delivers extended range of vision while maintaining a monofocal-like visual disturbance profile 1,2
PC-IOL option for cataract patients who may not be a candidate for a diffractive IOL
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, has commercially launched the first and only non-diffractive extended depth of focus intraocular lens (IOL) in the U.S. the AcrySof IQ Vivity
TM IOL (Vivity). This new presbyopia-mitigating lens is now available to all U.S. ophthalmologists for patients undergoing cataract surgery. Cataracts are the most common cause of vision loss globally.
American Aires Inc.: American Aires Receives DTC Eligibility Company or Aires ) has received approval from the Depository Trust Company to make its common shares, traded on the OTCQB under the symbol AAIRF, now eligible for electronic clearing and settlement through DTC s automated processes.
This electronic method of clearing securities speeds up the receipt of stock and cash, and thus accelerates the settlement process for investors and brokers while cutting costs and providing access to a wider network of brokerage firms, enabling the stock to be traded over a wider selection of firms by coming into compliance with their requirements. Obtaining DTC eligibility demonstrates Aires commitment to increasing visibility and accessibility for our shareholders, stated Dimitry Serov, President and CEO. We expect that access to DTC s platform will enhance liquidity and increase trading volume, presenting American Aires to an even broader range of investors in the United States.
PerkinElmer, Inc.: PerkinElmer to Acquire Oxford Immunotec Global PLC
Transaction expected to be completed in the first half of 2021
PerkinElmer, Inc. (NYSE: PKI) (
Oxford Immunotec or the
Company ) are pleased to announce they have reached an agreement on terms under which PerkinElmer will acquire Oxford Immunotec (the
Acquisition ). It is intended that the Acquisition will be implemented by means of a U.K. High Court of Justice-sanctioned scheme of arrangement under Part 26 of the U.K. Companies Act 2006 between Oxford Immunotec and its shareholders (the
Scheme
Under the terms of the Acquisition, Oxford Immunotec shareholders will be entitled to receive USD 22.00 in cash for each outstanding ordinary share (